Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.

Track this case

Case Number:

1:23-cv-00101

Court:

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Judge:

Colm F. Connolly

Firms

Companies

Sectors & Industries:

Healthcare
- Biotechnology
- Major

January 06, 2026
Drugmakers Fight Multifront Legal Battles Over GLP-1s

In the wake of U.S. Food and Drug Administration approvals for GLP-1 weight-loss drugs, surging public demand and massive profits have inspired a broad range of drugmaker litigation against competitors, alleged counterfeits and telehealth providers.
July 23, 2025
Judge Clears Mylan On 1 Novo Nordisk Patent In Wegovy Suit

A Delaware federal judge has found that proposed labeling for a generic version of the weight loss drug Wegovy doesn't recommend doctors prescribe it in a way covered by a Novo Nordisk patent on the brand-name treatment.